Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome | BMC Medical Research Methodology | Full Text
Designing clinical trials with (restricted) mean survival time endpoint: Practical considerations - Anne Eaton, Terry Therneau, Jennifer Le-Rademacher, 2020
Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation | JACC: Heart Failure
Restricted mean survival time (RMST) as the area under the curve. (A)... | Download Scientific Diagram
Comparison of Hazard Ratio and Restricted Mean Survival Analysis for Cardiorenal Drug Trials
Restricted Mean Survival Time (RMST) | by Anyi Guo | Medium
Estimating restricted mean survival time and expected life-years lost in the presence of competing risks within flexible parametric survival models | BMC Medical Research Methodology | Full Text
cox model - Restricted Mean Survival Time vs Hazard Ratio - How to describe the differences? - Cross Validated
How to calculate restricted mean survival time for covariates in R? - Stack Overflow
Comparison of Hazard Ratio and Restricted Mean Survival Analysis for Cardiorenal Drug Trials
Visualization of restricted mean survival time analysis. a Restricted... | Download Scientific Diagram
Calculating Restricted Mean Survival Time
Tisagenlecleucel in Non-Hodgkin Lymphoma: The Restricted Mean Survival Time as a Tool for Estimating Progression-Free Life Expectancy Better than the Median | Semantic Scholar
Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study | PLOS ONE
survRM2-vignette3-2.knit
Comparison of the restricted mean survival time with the hazard ratio in superiority trials with a time‐to‐event end point - Huang - 2018 - Pharmaceutical Statistics - Wiley Online Library
Analyzing differences between restricted mean survival time curves using pseudo-values | BMC Medical Research Methodology | Full Text
Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study | PLOS ONE
Graphic representation of restricted mean survival time and its... | Download Scientific Diagram
Difference in restricted mean survival time estimated using the Pooled... | Download Scientific Diagram
![PDF] Restricted mean survival time for the analysis of cardiovascular outcome trials assessing non-inferiority: Case studies from antihyperglycemic drug development. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3e44c5c7f36a8a9cef47c5c948c038c62cc29280/4-Figure1-1.png "PDF] Restricted mean survival time for the analysis of cardiovascular outcome trials assessing non-inferiority: Case studies from antihyperglycemic drug development. | Semantic Scholar")
PDF] Restricted mean survival time for the analysis of cardiovascular outcome trials assessing non-inferiority: Case studies from antihyperglycemic drug development. | Semantic Scholar
Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation - ScienceDirect
Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation - ScienceDirect
RMST of Standardized Survival Functions | Paul C. Lambert
Analyzing Restricted Mean Survival Time Using SAS/STAT®
Gini's mean difference and the long-term prognostic value of nodal quanta classes after pre-operative chemotherapy in advanced breast cancer | Scientific Reports
